| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/03/2013 | US20130005716 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 01/03/2013 | US20130005708 Histamine antagonist treatment of inflammatory skin disorders |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005680 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture |
| 01/03/2013 | US20130005660 Plasma Activation of Biological Materials for Surface Modification |
| 01/03/2013 | US20130005647 Mutant nisin ser 29 derivatives and the use thereof |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130004595 Compositions and Methods for Treating Skin Conditions |
| 01/03/2013 | US20130004590 Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/03/2013 | US20130004589 Divalent cation/anion pair containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/03/2013 | US20130004588 Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/03/2013 | US20130004583 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use |
| 01/03/2013 | US20130004580 Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/03/2013 | US20130004559 Flat self-curling permeable sheet membrane |
| 01/03/2013 | US20130004555 Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol |
| 01/03/2013 | US20130004554 Microalgae-Derived Compositions for Improving the Health and Appearance of Skin |
| 01/03/2013 | US20130004546 Hydrogel of microspheres |
| 01/03/2013 | US20130004543 Fibronectin: growth factor chimeras |
| 01/03/2013 | US20130004533 Platelet-derived growth factor-bb production promotor, and mesenchymal stem cell production accelerator, stem cell stabilizer and dermal regenerator comprising the same |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004499 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004478 Procoagulant Peptides and Their Derivatives and Uses Therefor |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004464 Multipotent adult stem cell population |
| 01/03/2013 | US20130004460 Silylated biomolecules |
| 01/03/2013 | US20130004444 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2840733A1 Retinoid topical compositions and methods for treating skin conditions |
| 01/03/2013 | CA2840612A1 Method for treating eczema |
| 01/03/2013 | CA2840606A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840568A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | CA2840480A1 Antipruritic agent |
| 01/03/2013 | CA2840290A1 Procoagulant peptides and their derivatives and uses therefor |
| 01/03/2013 | CA2839398A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| 01/03/2013 | CA2838976A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | CA2837453A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/02/2013 | EP2540305A1 Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/02/2013 | EP2540303A1 Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/02/2013 | EP2540302A1 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2540296A1 Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 01/02/2013 | EP2540292A1 DHA and EPA in the reduction of oxidative stress |
| 01/02/2013 | EP2540291A1 Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/02/2013 | EP2540290A1 Adapalene for the long-term treatment of acne vulgaris |
| 01/02/2013 | EP2539356A1 Modulation of smad3 expression |
| 01/02/2013 | EP2538978A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 01/02/2013 | EP2538963A1 Method of treatment or prevention of hair loss or for the enhancement of hair growth |
| 01/02/2013 | EP2538952A1 Method for favoring the restoration of a bodily function using hair root sheath cells, preparation and method for production thereof |
| 01/02/2013 | EP2538949A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 01/02/2013 | EP2538948A1 Biodegradable material containing silicon, for pro-angiogenetic therapy |
| 01/02/2013 | EP2538942A1 Treatment of dermatological allergic conditions |
| 01/02/2013 | EP2538941A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 01/02/2013 | EP2538938A1 Fungal nail treatment composition |
| 01/02/2013 | EP2538936A1 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation |
| 01/02/2013 | EP2538933A2 Use of essential oil of oregano or rosewood in the treatment of malign keratosis |
| 01/02/2013 | EP2538932A2 Use of essential oil of oregano or rosewood in the treatment of actinic keratosis |
| 01/02/2013 | EP2538920A1 Emollient foams for treatment of dermatoses |
| 01/02/2013 | CN202637530U Acne plaster |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858751A Cysteine protease inhibitors |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102858360A Methods for treating diabetic foot ulcers |
| 01/02/2013 | CN102858336A Treatment of dermatological allergic conditions |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102858329A Compounds for use in the treatment of diseases |
| 01/02/2013 | CN102858321A Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives |
| 01/02/2013 | CN102851254A Procurement, isolation, and cryopreservation of endometrial/menstrual cells |
| 01/02/2013 | CN102850324A Indole compounds |
| 01/02/2013 | CN102847126A Deer-horn glue qi-blood tonifying tablets |
| 01/02/2013 | CN102847116A Betel nut tablets with function of beriberi removing |
| 01/02/2013 | CN102847111A Tongli heat purging capsule |
| 01/02/2013 | CN102847110A Pill for tonifying Qi and restraining sore |
| 01/02/2013 | CN102847100A Tablets for treating external cold |
| 01/02/2013 | CN102847096A External traditional Chinese medicinal composition for treating hircismus |
| 01/02/2013 | CN102847087A Preparation process of integration-type novel formulation of Cinnamomum cassia, Paeonia lactiflora and Anemarrhena asphodeloides decoction and production method thereof |
| 01/02/2013 | CN102847085A Preparation process and production method for Magnolia Officinalis Seven-Ingredient Decoction preparation in an integrated new dosage form |
| 01/02/2013 | CN102847057A Preparation method of traditional Chinese medicine lotion for treating garlic-philic ecthyma |
| 01/02/2013 | CN102847030A Freckle-removal facial mask |
| 01/02/2013 | CN102847029A Chinese herbal medicinal lotion for treating dermatopathy |
| 01/02/2013 | CN102847020A Preparation method of traditional Chinese medicine wet tissue for clearing heat, detoxifying, promoting diuresis and relieving itching |
| 01/02/2013 | CN102847019A Chinese medicinal ointment for treating burns and scalds and preparation method thereof |
| 01/02/2013 | CN102847004A Traditional Chinese medicine for treating psoriasis by using cornu bubali |
| 01/02/2013 | CN102847003A Drug for treating facial acne |
| 01/02/2013 | CN102846999A A Chinese medicinal formulation for treating chloasma |
| 01/02/2013 | CN102846991A Ointment for treating burn or scald |
| 01/02/2013 | CN102846972A Drug for treating alopecia |
| 01/02/2013 | CN102846970A Traditional Chinese medicine application for treating psoriasis |
| 01/02/2013 | CN102846968A External ointment for burn and scald wound treatment |
| 01/02/2013 | CN102846953A Processing method of Anoectochilus roxburghii decoction pieces |
| 01/02/2013 | CN102846952A Method for processing anoectochilus roxburghii purely-fragrant decoction piece |
| 01/02/2013 | CN102846949A Traditional Chinese medicinal liquor |
| 01/02/2013 | CN102846941A Medicine for treating acne |
| 01/02/2013 | CN102846935A Preparation technology and production method for an integrated new formulation of fluid-increasing decoction |